Genebank - Funding Core Activities (2017-2021) - Amazon Web ...
Genebank - Funding Core Activities (2017-2021) Philip Chiverton Chair Peer Review Team (PRT)
Background FC 12: Discussion on value of genebanks and need for a continuation plan.
FC 13: Agreement on 2017-2021 support. Genebank Option Paper, PRT recommendations,
FC decision to commit $93.1m for the period 2017-2021, Blended approach to funding, Need for a Levy for “relevant CRPs”,
PRT tasked to explore different solutions and report at FC14. FC14: Reach agreement on optimal levy model
Relevant CRPs?
2014 Budget ($m) W1/2
W3
Bil
W3/Bil
Total
WHEAT
17.2
7.9
13.6
21.5
38.7
MAIZE
19.1
13.3
27.9
41.2
60.3
GRiSP (Rice)
35.2
23.6
35.1
58.7
93.9
Roots, Tubers & Bananas
31.1
20.3
23.7
44
75.1
Grain Legumes
16.4
13.3
16.3
29.6
46.0
Dryland Cereals
8.6
5.6
7.2
12.8
21.4
Forests, Trees, Agroforestry
30.4
12.4
35.6
48
78.4
Total
158
96.4
159.4
255.8
413.8
Principles (today)
Principles (2017-2021)
Modeling different levies ONLY Window 3/Bilateral
Budget as of 2014
Different Levies
Modeling different levies Including Window 2 = (W2, 3 + bilateral)
Budget as of 2014
Different Levies
Refining options… • Taking into consideration that Window 1 contribution to the Genebank programme is a safety net, other sources of funding (e.g. CRP line item for genebanks support) should represent the majority of the contribution (i.e. greater that 50%). • It is also assumed that in no circumstances, the income generated from CRPs should exceed the amount required to support the Genebank programme.
Refining options…
Modeling (2017-2021) 4% Levy on Window 3 and bilateral funds
3% Levy on Window 2, 3 and bilateral funds
30.0
30
25.0
25
20.0
20 15.7
15.0
16.1
12.8
15
8.5
13.2 8.9
4.3 0.8
10.0
4.7
5.0
5
-
0 2017
2018
2019
2020
2021
1.2
10
2017
Levy contribution Window 1 ‘Safety Net’
2018
2019
2020
2021
Post-2021 GCDT – Endowment ≈ 80%
CGIAR Fund + Levy ≈ 20%
Post-2021 3% Levy on Window 2, 3 and bilateral funds 30 25 20 16.1 15
13.2 8.9 4.7
1.2
10
3% Levy on Window 2, 3 and bilateral May exceed the required funding from the CGIAR Fund to the Genebank Programme
5 0 2017
2018
2019
2020
Levy contribution
2021
2022
Recommendations 1. The Fund Council is invited to approve a Genebank levy on relevant CRPs of a minimum of 3% on Window 2, 3 and bilateral funds only applicable to relevant CRPs, which should be, included as a line item in relevant CRP budgets. 2. The Fund Office and Consortium Office should be invited to confirm the list of ‘relevant CRPs’ within the new CRP portfolio and provide more accurate financial projections by end of 2016, based on the final CRP 2nd Call proposals budget approved at the end of 2016 by the Council. 3. The Fund Council may want to consider a possible reduction of such levy from 3% to 2% post 2021 conditional on effective collection of the proposed levy during the period 2017-2021 (and confirmation from the Trust Endowment post 2021 contribution).
Background FC 12: Discussion on value of genebanks and need for a continuation plan.
FC 13: Agreement on 2017-2021 support. Genebank Option Paper, PRT recommendations,
FC decision to commit $93.1m for the period 2017-2021, Blended approach to funding, Need for a Levy for “relevant CRPs”,
PRT tasked to explore different solutions and report at FC14. FC14: Reach agreement on optimal levy model
Relevant CRPs?
2014 Budget ($m) W1/2
W3
Bil
W3/Bil
Total
WHEAT
17.2
7.9
13.6
21.5
38.7
MAIZE
19.1
13.3
27.9
41.2
60.3
GRiSP (Rice)
35.2
23.6
35.1
58.7
93.9
Roots, Tubers & Bananas
31.1
20.3
23.7
44
75.1
Grain Legumes
16.4
13.3
16.3
29.6
46.0
Dryland Cereals
8.6
5.6
7.2
12.8
21.4
Forests, Trees, Agroforestry
30.4
12.4
35.6
48
78.4
Total
158
96.4
159.4
255.8
413.8
Principles (today)
Principles (2017-2021)
Modeling different levies ONLY Window 3/Bilateral
Budget as of 2014
Different Levies
Modeling different levies Including Window 2 = (W2, 3 + bilateral)
Budget as of 2014
Different Levies
Refining options… • Taking into consideration that Window 1 contribution to the Genebank programme is a safety net, other sources of funding (e.g. CRP line item for genebanks support) should represent the majority of the contribution (i.e. greater that 50%). • It is also assumed that in no circumstances, the income generated from CRPs should exceed the amount required to support the Genebank programme.
Refining options…
Modeling (2017-2021) 4% Levy on Window 3 and bilateral funds
3% Levy on Window 2, 3 and bilateral funds
30.0
30
25.0
25
20.0
20 15.7
15.0
16.1
12.8
15
8.5
13.2 8.9
4.3 0.8
10.0
4.7
5.0
5
-
0 2017
2018
2019
2020
2021
1.2
10
2017
Levy contribution Window 1 ‘Safety Net’
2018
2019
2020
2021
Post-2021 GCDT – Endowment ≈ 80%
CGIAR Fund + Levy ≈ 20%
Post-2021 3% Levy on Window 2, 3 and bilateral funds 30 25 20 16.1 15
13.2 8.9 4.7
1.2
10
3% Levy on Window 2, 3 and bilateral May exceed the required funding from the CGIAR Fund to the Genebank Programme
5 0 2017
2018
2019
2020
Levy contribution
2021
2022
Recommendations 1. The Fund Council is invited to approve a Genebank levy on relevant CRPs of a minimum of 3% on Window 2, 3 and bilateral funds only applicable to relevant CRPs, which should be, included as a line item in relevant CRP budgets. 2. The Fund Office and Consortium Office should be invited to confirm the list of ‘relevant CRPs’ within the new CRP portfolio and provide more accurate financial projections by end of 2016, based on the final CRP 2nd Call proposals budget approved at the end of 2016 by the Council. 3. The Fund Council may want to consider a possible reduction of such levy from 3% to 2% post 2021 conditional on effective collection of the proposed levy during the period 2017-2021 (and confirmation from the Trust Endowment post 2021 contribution).
